BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15325851)

  • 21. Prenatal strategies for reducing severe thalassemia in pregnancy.
    Wanapirak C; Tongsong T; Sirivatanapa P; Sa-nguansermsri T; Sekararithi R; Tuggapichitti A
    Int J Gynaecol Obstet; 1998 Mar; 60(3):239-44. PubMed ID: 9544707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False positive rates of thalassemia screening in rural clinical setting: 10-year experience in Thailand.
    Jopang Y; Thinkhamrop B; Puangpruk R; Netnee P
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):576-80. PubMed ID: 19842446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of naked eye single tube red cell osmotic fragility test in detecting beta-thalassemia trait.
    Raghavan K; Lokeshwar MR; Birewar N; Nigam V; Manglani MV; Raju NB
    Indian Pediatr; 1991 May; 28(5):469-72. PubMed ID: 1752672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of red cell osmotic fragility test with varying degrees of saline concentration in detecting beta-thalassaemia trait.
    Singh SP; Gupta SC
    Singapore Med J; 2008 Oct; 49(10):823-6. PubMed ID: 18946618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for beta-thalassaemia carriers in Egypt: significance of the osmotic fragility test.
    El-Beshlawy A; Kaddah N; Moustafa A; Mouktar G; Youssry I
    East Mediterr Health J; 2007; 13(4):780-6. PubMed ID: 17955759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy.
    Srisupundit K; Piyamongkol W; Tongsong T
    Am J Hematol; 2008 Dec; 83(12):908-10. PubMed ID: 18932192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and hematological characteristics of beta-thalassemia trait in Gaziantep urban area, Turkey.
    Gurbak M; Sivasli E; Coskun Y; Bozkurt AI; Ergin A
    Pediatr Hematol Oncol; 2006; 23(5):419-25. PubMed ID: 16728362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemoglobinopathy screening by osmotic fragility test based on flow cytometer or naked eye.
    Mohapatra R; Warang P; Ghosh K; Colah R
    Cytometry B Clin Cytom; 2016 May; 90(3):279-84. PubMed ID: 25515688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Thalassaemia Screening Tests in the Antenatal and Non-Antenatal Populations in Singapore.
    Lee SY; Yap ES; Lee EY; Goh JH; Liu TC; Yip C
    Ann Acad Med Singap; 2019 Jan; 48(1):5-15. PubMed ID: 30788489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity and specificity of single-tube osmotic fragility test and its different methods as screening test for thalassemia trait: an alternative to expensive laboratory tests for resource-limited countries.
    Ansari SH; Hanifa A; Saleem A; Ali SM; Hussain Z; Zohaib M; Akbar M; Rehman S; Hussain SR
    Eur J Haematol; 2014 Dec; 93(6):516-20. PubMed ID: 24912950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of iron deficiency anemia in pregnant women in Nakhonsawan, Thailand.
    Sukrat B; Suwathanapisate P; Siritawee S; Poungthong T; Phupongpankul K
    J Med Assoc Thai; 2010 Jul; 93(7):765-70. PubMed ID: 20649053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple screening test for the detection of heterozygous beta thalassemia.
    Thool AA; Walde MS; Shrikhande AV; Talib VH
    Indian J Pathol Microbiol; 1998 Oct; 41(4):423-6. PubMed ID: 9866902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic Value of HBA
    Peng R; Gu HY; Qin M; Zhang HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):217-220. PubMed ID: 33554823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalassemia and hemoglobinopathies in pregnant Lao women: carrier screening, prevalence and molecular basis.
    Savongsy O; Fucharoen S; Fucharoen G; Sanchaisuriya K; Sae-Ung N
    Ann Hematol; 2008 Aug; 87(8):647-54. PubMed ID: 18414862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
    Ong CY; Lee CP; Leung KY; Lau E; Tang MH
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NESTROFT: a screening test for beta thalassemia trait.
    Mehta BC
    Indian J Med Sci; 2002 Nov; 56(11):537-45. PubMed ID: 14510336
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimal cutoff of mean corpuscular volume (MCV) for screening of alpha-thalassemia 1 trait.
    Nunchai C; Sirichotiyakul S; Tongsong T
    J Obstet Gynaecol Res; 2020 May; 46(5):774-778. PubMed ID: 32077202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of gestational diabetes mellitus (GDM) in women screened by glucose challenge test (GCT) at Maharaj Nakorn Chiang Mai Hospital.
    Chanprapaph P; Sutjarit C
    J Med Assoc Thai; 2004 Oct; 87(10):1141-6. PubMed ID: 15560687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on gene mutation spectrums of α- and β-thalassemias in populations of Yunnan Province and the prenatal gene diagnosis].
    Zhu BS; He J; Zhang J; Zeng XH; Su J; Xu XH; Li SY; Chen H; Zhang YH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):85-9. PubMed ID: 22455737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NESTROFF as a screening test for detection of Beta-thalassemia trait.
    Bobhate SK; Gaikwad ST; Bhaledrao T
    Indian J Pathol Microbiol; 2002 Jul; 45(3):265-7. PubMed ID: 12785163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.